Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
Top Cited Papers
- 31 July 2004
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 5 (7), 419-429
- https://doi.org/10.1016/s1470-2045(04)01509-8
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Leptin Induces Endothelial Cell Migration Through Akt, Which Is Inhibited by PPARγ-LigandsHypertension, 2002
- Peroxisome proliferator-activated receptor γ reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1Life Sciences, 2002
- Peroxisome Proliferator-Activated Receptor γ Induces Pancreatic Cancer Cell ApoptosisBiochemical and Biophysical Research Communications, 2001
- Troglitazone Inhibits Growth of MCF-7 Breast Carcinoma Cells by Targeting G1 Cell Cycle RegulatorsBiochemical and Biophysical Research Communications, 2001
- Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell linesHepatology, 2001
- PPARγ Inhibits the Expression of c-MET in Human Gastric Cancer Cells through the Suppression of EtsBiochemical and Biophysical Research Communications, 1999
- Expression of Peroxisome Proliferator Activated Receptor mRNA in Normal and Tumorigenic Rodent Mammary GlandsBiochemical and Biophysical Research Communications, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator Activated Receptors γ1 and γ2Biochemical and Biophysical Research Communications, 1996
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994